Free Trial

Colgate-Palmolive (CL) Stock Forecast & Price Target

Colgate-Palmolive logo
$87.31 -0.23 (-0.26%)
As of 01/7/2025 03:58 PM Eastern

Colgate-Palmolive - Analysts' Recommendations and Stock Price Forecast (2025)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Sell
1
Hold
9
Buy
12

Based on 22 Wall Street analysts who have issued ratings for Colgate-Palmolive in the last 12 months, the stock has a consensus rating of "Moderate Buy." Out of the 22 analysts, 1 has given a sell rating, 9 have given a hold rating, and 12 have given a buy rating for CL.

Consensus Price Target

$104.16
19.30% Upside
According to the 22 analysts' twelve-month price targets for Colgate-Palmolive, the average price target is $104.16. The highest price target for CL is $122.00, while the lowest price target for CL is $83.00. The average price target represents a forecasted upside of 19.30% from the current price of $87.31.
Get the Latest News and Ratings for CL and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Colgate-Palmolive and its competitors.

Sign Up

CL Analyst Ratings Over Time

TypeCurrent Forecast
1/9/24 to 1/8/25
1 Month Ago
12/10/23 to 12/9/24
3 Months Ago
10/11/23 to 10/10/24
1 Year Ago
1/9/23 to 1/9/24
Strong Buy
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
12 Buy rating(s)
12 Buy rating(s)
13 Buy rating(s)
9 Buy rating(s)
Hold
9 Hold rating(s)
9 Hold rating(s)
8 Hold rating(s)
3 Hold rating(s)
Sell
1 Sell rating(s)
1 Sell rating(s)
1 Sell rating(s)
0 Sell rating(s)
Consensus Price Target$104.16$105.11$104.74$84.14
Forecasted Upside19.30% Upside13.08% Upside5.54% Upside4.11% Upside
Consensus Rating
Moderate Buy
Moderate Buy
Moderate Buy
Moderate Buy

CL Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

CL Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Colgate-Palmolive Stock vs. The Competition

TypeColgate-PalmoliveConsumer Staples CompaniesS&P 500
Consensus Rating Score
2.50
2.49
2.51
Consensus RatingModerate BuyHoldModerate Buy
Predicted Upside19.30% Upside45.05% Upside15.00% Upside
News Sentiment Rating
Positive News

See Recent CL News
Positive News
Positive News
DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
1/7/2025Wells Fargo & Company
3 of 5 stars
C. Carey
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower TargetUnderweight ➝ Underweight$92.00 ➝ $83.00-5.98%
1/6/2025Piper Sandler
2 of 5 stars
 Lower TargetOverweight ➝ Overweight$121.00 ➝ $112.00+27.01%
10/28/2024TD Cowen
5 of 5 stars
R. Moskow
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower TargetBuy ➝ Buy$115.00 ➝ $110.00+16.40%
10/28/2024Stifel Nicolaus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 DowngradeBuy ➝ Hold$105.00 ➝ $101.00+5.64%
10/11/2024JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetOverweight ➝ Overweight$113.00 ➝ $114.00+14.87%
9/9/2024Deutsche Bank Aktiengesellschaft
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 DowngradeBuy ➝ Hold$107.00 ➝ $109.00+1.06%
9/4/2024UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetBuy ➝ Buy$119.00 ➝ $122.00+11.95%
8/1/2024Redburn Atlantic
Subscribe to MarketBeat All Access for the recommendation accuracy rating
E. Lewis
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeHold
7/30/2024Sanford C. Bernstein
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetMarket Perform ➝ Market Perform$100.00 ➝ $103.00+3.00%
7/29/2024Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetOverweight ➝ Overweight$103.00 ➝ $111.00+10.46%
7/29/2024Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetEqual Weight ➝ Equal Weight$91.00 ➝ $96.00-4.61%
7/26/2024Hsbc Global Res
Subscribe to MarketBeat All Access for the recommendation accuracy rating
A. Zamacona
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeStrong-Buy ➝ Hold
7/26/2024HSBC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingBuy ➝ Hold
7/24/2024Jefferies Financial Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 DowngradeBuy ➝ Hold$103.00 ➝ $95.00-1.61%
7/18/2024Evercore ISI
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetOutperform ➝ Outperform$100.00 ➝ $106.00+6.91%
7/10/2024Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetBuy ➝ Buy$103.00 ➝ $112.00+15.00%
7/10/2024Bank of America
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetBuy ➝ Buy$100.00 ➝ $110.00+13.26%
6/24/2024BNP Paribas
Subscribe to MarketBeat All Access for the recommendation accuracy rating
K. Grundy
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageOutperform$109.00+12.06%
5/15/2024Argus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
C. Graja
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost TargetBuy ➝ Buy$97.00 ➝ $107.00+13.01%
4/29/2024Royal Bank of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetSector Perform ➝ Sector Perform$88.00 ➝ $95.00+4.38%
3/1/2024The Goldman Sachs Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Initiated CoverageBuy$93.00+7.50%
1/29/2024Raymond James
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 UpgradeMarket Perform ➝ Outperform$91.00+9.86%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Wednesday at 08:45 AM ET.


Should I Buy Colgate-Palmolive Stock? CL Pros and Cons Explained

These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Monday, December 30, 2024. Please send any questions or comments about these Colgate-Palmolive pros and cons to contact@marketbeat.com.

Colgate-Palmolive
Bull Case

green Wall Street bull icon

Here are some ways that investors could benefit from investing in Colgate-Palmolive:

  • Colgate-Palmolive has a strong market capitalization of approximately $75.19 billion, indicating a robust financial position and stability in the consumer products sector.
  • The company recently announced a quarterly dividend of $0.50 per share, translating to an annualized dividend of $2.00 and a yield of 2.17%. This consistent dividend payment can provide a steady income stream for investors.
  • Colgate-Palmolive's stock price recently traded at $93.58, which is relatively close to its 52-week high of $109.30, suggesting potential for price appreciation.
  • Analysts have a consensus price target of $105.11 for Colgate-Palmolive, with a majority rating it as a "Hold" or "Buy," indicating positive sentiment and potential for growth.
  • The company has a low beta of 0.43, suggesting that its stock is less volatile compared to the market, which can be appealing for risk-averse investors.

Colgate-Palmolive
Bear Case

red Wall Street bear icon

Investors should be bearish about investing in Colgate-Palmolive for these reasons:

  • Recent insider trading activity, including a significant sale by the CFO, may raise concerns about the company's future performance and insider confidence.
  • The company's P/E ratio of 26.37 indicates that the stock may be overvalued compared to its earnings, which could deter value-focused investors.
  • Colgate-Palmolive's PEG ratio of 3.31 suggests that the stock's price is high relative to its expected earnings growth, which may not justify the current valuation.
  • Brokerage ratings have shown mixed signals, with some firms downgrading their ratings and price targets, indicating uncertainty in the stock's future performance.
  • The company's debt-to-equity ratio of 9.46 is quite high, suggesting that it relies heavily on debt financing, which could pose risks in a rising interest rate environment.

CL Forecast - Frequently Asked Questions

According to the research reports of 22 Wall Street equities research analysts, the average twelve-month stock price forecast for Colgate-Palmolive is $104.16, with a high forecast of $122.00 and a low forecast of $83.00.

22 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Colgate-Palmolive in the last twelve months. There is currently 1 sell rating, 9 hold ratings and 12 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "moderate buy" CL shares.

According to analysts, Colgate-Palmolive's stock has a predicted upside of 19.30% based on their 12-month stock forecasts.

Over the previous 90 days, Colgate-Palmolive's stock had 1 downgrade by analysts.

Colgate-Palmolive has been rated by research analysts at JPMorgan Chase & Co., Piper Sandler, Stifel Nicolaus, TD Cowen, and Wells Fargo & Company in the past 90 days.

Analysts like Colgate-Palmolive more than other "consumer staples" companies. The consensus rating for Colgate-Palmolive is Moderate Buy while the average consensus rating for "consumer staples" companies is Hold. Learn more on how CL compares to other companies.


This page (NYSE:CL) was last updated on 1/8/2025 by MarketBeat.com Staff
From Our Partners